COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 15:00, il y a 1 année 7 mois Focus Universal Announces SEC Financial Reporting Software Achieves Thousand Times Faster Than Traditional Manual Approach and Launches Nationwide Non-Deal Roadshow Focus Universal Inc. (NASDAQ:FCUV) announces revolutionary SEC financial reporting software, generating reports thousands of times faster than traditional methods, enhancing efficiency and accuracy in financial reporting Focus Universal Inc. Financial Reporting Efficiency Accuracy SEC Financial Reporting Software
COMMUNIQUÉ RÉGLEMENTÉ publié le 12/08/2024 à 14:47, il y a 1 année 7 mois Weekly reports share buyback from August 5th to 9th 2024. Guillemot Corporation S.A. reported share buyback transactions from August 5th to 9th, 2024, under a buyback program on Euronext Paris Euronext Paris Transactions Share Buyback Financial Report Guillemot Corporation
COMMUNIQUÉ RÉGLEMENTÉ publié le 12/08/2024 à 14:47, il y a 1 année 7 mois Déclaration hebdomadaire des transactions sur actions propres du 5 au 9 août 2024. Déclaration hebdomadaire des transactions sur actions propres de Guillemot Corporation S.A. du 5 au 9 août 2024. Transactions réalisées dans le cadre du programme de rachat via un prestataire indépendant Actions Propres Euronext Paris Transactions Guillemot Corporation Rachat
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 14:45, il y a 1 année 7 mois Atlas Salt Announces De-risked Development Schedule for Great Atlantic Salt Project Atlas Salt Inc. announces de-risked development schedule for Great Atlantic Salt Project with 3rd party verification by Tamkali Limited. Project's duration reduced to 59 months, enhancing details, and incorporating PERT analysis and Oracle Primavera Cloud Software Atlas Salt Inc. Great Atlantic Salt Project Project Schedule Tamkali Limited PERT Analysis
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 14:30, il y a 1 année 7 mois Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration Monogram Technologies Inc. announces clinical trial collaboration with Shalby Limited for mBÈs TKA System, following 510(k) submission and FDA approval. Shalby recognized as global leader in orthopedic surgeries FDA Approval Clinical Trial Monogram Technologies Inc. Shalby Limited MBÈs TKA System
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 14:00, il y a 1 année 7 mois Grand Island Express Achieves Record-Breaking Efficiency and Revenue Gains With Optimal Dynamics’ Software Optimal Dynamics' Artificial Decision Intelligence drives significant revenue, load count, and operational efficiency for Grand Island Express trucking company, leading to record-breaking results and high adoption rate Optimal Dynamics Artificial Decision Intelligence Grand Island Express Truck Record-breaking Results
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 14:00, il y a 1 année 7 mois MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor MIRA Pharmaceuticals unveils new preclinical data on innovative drug candidate Ketamir-2's metabolite Nor-Ketamir-2, showcasing enhanced bioavailability and formulation for advanced at-home neurological treatments Neurological Treatments Preclinical Data Bioavailability MIRA Pharmaceuticals Ketamir-2
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 14:00, il y a 1 année 7 mois STMicroelectronics Announces Status of Common Share Repurchase Program STMicroelectronics N.V. announces details of common share repurchase program from Aug 05 to Aug 09, 2024, repurchasing 373,000 shares at EUR 26.6520 per share for a total of EUR 9,941,210.60 Euronext Paris Market Abuse Regulation Treasury Shares Share Repurchase Program STMicroelectronics
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 13:30, il y a 1 année 7 mois Beyond Oil Enters into LOI with One of the World's Largest Global Food Equipment Manufacturers Beyond Oil Ltd. and Industrial Manufacturer collaborate on state-of-the-art Joint Filtration System for industrial frying market, aiming for healthier, more sustainable food. Beyond Oil's innovative product showcased exceptional performance in preliminary tests Beyond Oil Ltd. Healthier Food Industrial Frying Market Industrial Manufacturer Joint Filtration System
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 13:09, il y a 1 année 7 mois Coinsilium Group Limited: Director Share Dealings Coinsilium Group Limited announces Director Share Dealings. Eddy Travia and Malcolm Palle purchase ordinary shares in the Company Ordinary Shares Coinsilium Group Limited Director Share Dealings Eddy Travia Malcolm Palle
Publié le 26/03/2026 à 18:17, il y a 4 heures 55 minutes Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Publié le 26/03/2026 à 18:17, il y a 4 heures 55 minutes Eiffage strengthens its position in Getlink capital
Publié le 26/03/2026 à 18:00, il y a 5 heures 12 minutes Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Publié le 26/03/2026 à 18:00, il y a 5 heures 12 minutes LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
Publié le 26/03/2026 à 23:00, il y a 12 minutes FutureGen Industries Announces Closing of Debt Settlement
Publié le 26/03/2026 à 22:05, il y a 1 heure 7 minutes BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Publié le 26/03/2026 à 22:00, il y a 1 heure 12 minutes Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Publié le 26/03/2026 à 22:00, il y a 1 heure 12 minutes Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Publié le 26/03/2026 à 21:00, il y a 2 heures 12 minutes Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Publié le 26/03/2026 à 20:48, il y a 2 heures 24 minutes Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Publié le 26/03/2026 à 19:20, il y a 3 heures 52 minutes Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Publié le 26/03/2026 à 19:09, il y a 4 heures 3 minutes 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Publié le 26/03/2026 à 19:09, il y a 4 heures 3 minutes 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)